Source: The Business Journals: San Francisco Business Times

Zymergen: Zymergen's last sales: Once-high-flying biotech company's equipment on auction block

Biotech startups could pick up deals from a onetime 800-employee company that landed a half-billion-dollar IPO months before things fell apart.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
500-1.0K
Jay Flatley's photo - Interim-CEO of Zymergen

Interim-CEO

Jay Flatley

CEO Approval Rating

82/100

Read more